Indian medical innovation is over again in glare of publicity in biotechnology sector as a leader in stem cell therapy and the credit goes to Dr Geeta Shroff, Founder and Medical Director, Nutech Mediworld in being granted 66th patent on ground breaking human embryonic stem cell technology to treat incurable diseases in Malaysia. Earlier in...

Gaining an insight into Traditional Knowledge Digital Library (TKDL) database will make one realize the magnitude and significance of Indian traditional medicinal system and heritage. Since primeval time, India has possessed an affluent traditional knowledge, which refers to knowledge inherent in aboriginal communities on diverse ways and means practiced to treat diseases, which have distressed...

The Delhi High Court in its interim order dated 17th July 2015, disposed off the appeal filed by Glenmark against the interim injunction awarded by a single judge of the Delhi High Court on 19th Jan 2015. The 19th Jan 2015 interim injunction restrained Glenmark from making linezolid on the ground that it violated Symed’s...

As per Thomson Reuter’s analysis of global patents, the life sciences industry is attaining increasing succession over technology-based sectors in terms of driving global innovation. The year 2014 has been full of patents application and successful grants than any other year in the history. This reflects the ingenious nature of civilization with relevance to few...

Genome editing, also referred to as genome editing with engineered nucleases (GEEN) is a category of genetic engineering, in which DNA is inserted, replaced, or removed from a genome using artificially engineered nucleases, or “molecular scissors.” The nucleases create specific double-stranded break (DSBs) at desired locations in the genome, and harness the cell’s endogenous mechanisms...

In a case reflecting the sorry state of affairs with respect to patent prosecution in India, the Intellectual Property Appellate Board (IPAB) had set aside the order passed by the Delhi Patent Office refusing patent to Pfizer’s anti-psychotic drug. Pfizer’s patent application (No. 1154/DEL/1997) was directed to Ziprasidone mesylate trihydrate for treatment of psychotic disorders....

Suven Life Sciences Ltd., from Hyderabad, specializing in research on new drug candidates for central nervous system (CNS) disorders had procured two new product patents – one from the European patent office (EPO) and another from Hongkong. Both the patents claim drug compounds (New Chemical Entities- NCEs) targeting a serotonin receptor that modulates the release...

The Indian Patent Office has refused patent to Wyeth, a group company of Pfizer Inc., in response to representation for Pre-grant opposition filed by Fresenius Kabi (formerly Dabur Pharma Ltd.). The pre-grant opposition is against a divisional patent application filed by Wyeth (1155/KOLNP/2007) claiming stable parenteral formulations having a rapamycin hydroxyester (CCI-779). The grounds for...

GVK Biosciences, a contract research organization that conducts clinical trials for many reputed generic manufacturers in India and foreign countries is facing rough weather following the harsh recommendations made by the European Medicines Agency (EMA). The trouble started for GVK last May when ANSM, the French drug regulatory agency alleged data manipulation of “check-out ECGs”...

Stempeutics Research, a stem cell research company having facilities in India as well as in Malaysia has obtained a Chinese patent (Chinese Application No. CN 201080053627) for its lead product-Stempeucel. The company has obtained patent rights in US as well (US 8956862) for the same technology. Stempeutics Research is the first company in the world...